A new campaign has been launched by Now Screen for Melotin MR, ‘A good day starts with a good night’s sleep’.
The announcement:
If daylight saving is playing havoc with your body clock, then Melotin MR could be for you.
Melatonin belongs to a group of naturally occurring hormones produced in the body. It helps by regulating the circadian rhythms and increasing the propensity to sleep.
Unfortunately, as we age, we produce less melatonin.
Consequently, melatonin supplements have been used for many years around the world to improve sleep quality, but most are only accessible via prescription in Australia.
The great news is Melotin MR, 2mg melatonin in a modified release formula, is now available without a prescription for people 55+ years old for the short term relief of primary insomnia. One simply needs to ask their pharmacist if this product is right for them.
“There is lots of information that supports the importance of quality sleep and its impact on one’s overall quality of life.” said Maui Valdes, General Manager, Consumer Brands at Arrotex Pharmaceuticals. “The recent down-scheduling allows for easier access to an efficacious medication like Melotin MR which is a huge benefit to those struggling with sleep and this campaign helps create greater awareness.”
The campaign idea is all about how a good day starts with a good night’s sleep. It shows in a very relatable way how challenging it can be to function after a bad night’s sleep. It reveals how Melotin MR – MR stands for Modified Release formula, helps regulate people’s internal body clock, to help them fall asleep more easily, improve their sleep quality and help them wake feeling alert.
“You know yourself if you haven’t slept properly, you feel in a bit of a daze and everything feels much harder the next day,” said Colin Murace, Client
Services Director at Now Screen. “Six espressos might get you through the morning, but eventually it catches up with you. Which is when we realized there’s nothing like a good night’s sleep to set you up for a good day.”
The multi-media campaign will run on FTA, BVOD, YouTube, Social, Spotify, Programmatic and POS
[Ask your pharmacist – they must decide if this product is right for you.
Short term treatment of primary insomnia characterised by poor quality sleep in adults aged 55 years or over. Primary insomnia is insomnia without an underlying medical or any other clear cause. Not to used concurrently with other treatments for insomnia.]
Client: Arrotex Pharmaceuticals
General Manager – Marketing: Maureen Valdes
Marketing Manager, Consumer Brands: Marcus Bolleurs
Creative Agency and Production Company: Now Screen
CEO: Mark Silcocks
Client Service Director: Colin Murace
Global Creative Director: Dana Holder
Senior Writer: Mardi McConnochie
Art Director: Manuel Rey
Global Producer: Tania Templeton
Producer: Renata Macri
Director: Jason Wingrove
Editor: Esteban de la Concha
Source: Now Screen media release